Telomir Pharmaceuticals, Inc. (TELO) News
Track canonical SquawkNews coverage tagged to TELO, Telomir Pharmaceuticals, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Telomir Pharmaceuticals says preclinical study restored AMD model visual function
The company said a peer-reviewed preclinical study found Telomir-Zn restored visual function and retinal structure in an AMD model.
EQUITY | Sep 17, 2026, 12:34 PM UTC
L
TELO - Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
TELO - Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD)
NEWS | Sep 17, 2026, 12:30 PM UTC